Phase 1 Startpositive
Phase 1 Start: BActinium-1: A Phase 1b, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Intrav
- Company
- Aktis Oncology Inc. (AKTS)
- Indication
- Prostate Cancer; mCRPC; Castration Resistant Metastatic Prostate Cancer
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.